Eversept Partners’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
Other funds holding UNCY
DIG
Eversept Partners's UNCY Position: Q3 2026 in Review
Eversept Partners opened a new position in Unicycive Therapeutics (UNCY) in Q3 2026: 336,000 shares worth $1.58M. The stake represents 0.08% of the portfolio and ranks #88 among its holdings.
90 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.
- Eversept Partners held 336,000 shares of Unicycive Therapeutics worth $1.58M as of Q3 2026.
- Unicycive Therapeutics was a new Eversept Partners position in Q3 2026.
- Unicycive Therapeutics made up 0.08% of Eversept Partners's portfolio in Q3 2026, its #88 holding.
- 90 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.
Based on Eversept Partners's 13F filing for Q3 2026, filed 16 Nov 2026.